Activity aim
This clinical audit activity presents latest evidence-based recommendations and PBS pathways for reducing cardiorenal risk in people with type 2 diabetes and comorbid cardiovascular disease, multiple cardiovascular risk factors and/or kidney disease. It also provides a practical framework for optimising the care of patients with T2D who are facing enhanced cardiorenal risk, using lifestyle and guideline-directed medical therapies.
Why take part in this program?
- Conduct follow-up consultations with 5 patients who have type 2 diabetes and high cardiovascular risk, to review and optimise their management
- Earn 6.5 CPD hours upon completion.
Inclusion criteria
Patients who are eligible for this clinical audit are adults who are:
- Adults aged 18 years and older
- Type 2 diabetes
- Currently managed with metformin (with or without SU)
- One or more of the following:
- Established CVD
- High risk of CVD
- Aboriginal or Torres Strait Islander
- Not currently undergoing concomitant PBS-subsidised treatment for diabetes with a SGLT2 inhibitor or a GLP-1 RA
How long should it take?
The program has been designed to take approximately 4-6 weeks to complete. This includes patient recall from your practice, patient consult and program evaluation.
Tips to recruit patients
Recruitment may occur:
- Opportunistically as you consult appropriate patients as part of usual care.
- By active recall.
Learning outcomes
Boost your Measuring Outcomes CPD hours with this new clinical audit
Related content
